The accuracy of elevated concentrations of endotoxin in bronchoalveolar lavage fluid for the rapid diagnosis of gram-negative pneumonia

被引:35
作者
Kollef, MH [1 ]
Eisenberg, PR [1 ]
Ohlendorf, MF [1 ]
Wick, MR [1 ]
机构
[1] WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110
关键词
D O I
10.1164/ajrccm.154.4.8887601
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The purpose of this study was to determine the accuracy of elevated concentrations of endotoxin in bronchoalveolar lavage (BAL) fluid for the diagnosis of gram-negative pneumonia. Sixty-three hospitalized adults underwent 71 evaluations with BAL using quantitative cultures for suspected lung infection. A cutoff value of > 5 EU/ml for the concentration of endotoxin in BAL fluid yielded the best operating characteristics for the diagnosis of gram-negative pneumonia (sensitivity, 100%; specificity, 75.0%; area under receiver operating characteristic [ROC] curve, 0.88). Good diagnostic agreement was found between elevated concentrations of endotoxin in BAL fluid and microbiologically confirmed gram-negative pneumonia (kappa statistic, 0.64; concordance 83.1%). Gram stain examination of BAL fluid for the presence of gram-negative bacteria yielded inferior operating characteristics (sensitivity, 63.2%; specificity, 75.0%; area under ROC curve, 0.69). Poor diagnostic agreement was observed between BAL fluid Gram stain results and microbiologically confirmed gram-negative pneumonia (kappa statistic, 0.35; concordance, 71.8%). These findings suggest that a concentration of endotoxin in BAL fluid > 5 EU/ml is superior to Gram stain examination for the rapid identification of patients with gram-negative pneumonia.
引用
收藏
页码:1020 / 1028
页数:9
相关论文
共 35 条
[1]   DECISION-MAKING IN NOSOCOMIAL PNEUMONIA - AN ANALYTIC APPROACH TO THE INTERPRETATION OF QUANTITATIVE BRONCHOSCOPIC CULTURES [J].
BAKER, AM ;
BOWTON, DL ;
HAPONIK, EF .
CHEST, 1995, 107 (01) :85-95
[2]   THE STANDARDIZATION OF CRITERIA FOR PROCESSING AND INTERPRETING LABORATORY SPECIMENS IN PATIENTS WITH SUSPECTED VENTILATOR-ASSOCIATED PNEUMONIA [J].
BASELSKI, VS ;
ELTORKY, M ;
COALSON, JJ ;
GRIFFIN, JP .
CHEST, 1992, 102 (05) :S571-S579
[3]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[4]   Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units [J].
Chastre, J ;
Fagon, JY ;
Trouillet, JL .
CLINICAL INFECTIOUS DISEASES, 1995, 21 :S226-S237
[5]  
CHASTRE J, 1988, AM J MED, V85, P499
[6]   EPIDEMIOLOGY OF NOSOCOMIAL PNEUMONIA - NEW PERSPECTIVES ON AN OLD DISEASE [J].
CRAVEN, DE ;
STEGER, KA .
CHEST, 1995, 108 (02) :S1-S16
[7]   THE EFFECT OF ANTIBIOTIC-THERAPY ON RECOVERY OF INTRACELLULAR BACTERIA FROM BRONCHOALVEOLAR LAVAGE IN SUSPECTED VENTILATOR-ASSOCIATED NOSOCOMIAL PNEUMONIA [J].
DOTSON, RG ;
PINGLETON, SK .
CHEST, 1993, 103 (02) :541-546
[8]  
FAGON JY, 1989, AM REV RESPIR DIS, V139, P87
[9]  
*FDA, 1987, HFN32 FDA CTR DRUG E
[10]  
Fleiss J. L., 1981, STAT METHODS RATES P, P598